Beijing Ql Biopharmaceutical Co.,ltd
Clinical trials sponsored by Beijing Ql Biopharmaceutical Co.,ltd, explained in plain language.
-
New injection ZT003 put to the test in first human safety study
Knowledge-focused Recruiting nowThis early-stage study tests whether ZT003 injection is safe and how the body processes it. About 76 healthy and overweight volunteers will receive either the drug or a placebo. The goal is to check for side effects and measure drug levels, not to treat any disease.
Phase: PHASE1 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
New obesity drug tested in kidney patients – safety first
Knowledge-focused Recruiting nowThis study looks at how a single shot of ZT002 (zovaglutide) behaves in the body and its safety in 40 adults with varying kidney function, including those with normal kidneys. Participants are overweight or obese and have stable chronic kidney disease. The goal is to understand h…
Phase: PHASE1 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC